• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1型糖尿病成年患者使用移动应用决策支持系统后1年内血糖变化分析]

[Analysis of glucose changes in adults with type 1 diabetes mellitus within 1 year after using mobile APP decision support system].

作者信息

Ding Y, Yue T, Wu W M, Zhou Y W, Luo S H, Zheng X Y, Weng J P, Chen Z F

机构信息

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.

Department of Endocrinology, Changshu Hospital of Traditional Chinese Medicine, Changshu 215516, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2022 Apr 26;102(16):1196-1201. doi: 10.3760/cma.j.cn112137-20211010-02240.

DOI:10.3760/cma.j.cn112137-20211010-02240
PMID:35462501
Abstract

To analyze the changes in glucose after using a decision support system (DSS) of a smartphone mobile application (APP) in adults with type 1 diabetes mellitus (T1DM). In the intervention study, the data (including general information at the time of registration) of adult T1DM patients enrolled in the Chinese T1DM Registration Management Project and registered with TangTangQuan® APP were collected. Within 1 year after registration, fasting blood glucose, pre-prandial and postprandial blood glucose at the three meals, blood glucose before bedtime and in nocturnal time were collected every 3 months. Frequencies of total recorded glucose values and proportion of different ranges of glycemia were also collected and analyzed, including the range between 3.9-7.8 mmol/L (Euglycemia), ranged below 3.9 mmol/L (Hypoglycemia) and range above 13.9 mmol/L (hyperglycemia). The patients were divided into 3 groups according to the daily use frequency of DSS (Low/Moderate/High frequency groups). The changes in point blood glucose, the proportion of hyperglycemia and hypoglycemia over time were compared among different groups, as well as the baseline characteristics and glucose characteristics of patients. A total of 629 eligible T1DM patients were included, including 216 (34.3%) males and 413 (65.7%) females, aged (31.5±10.8) years, and disease duration [(, )] of 1.2 (0.1, 7.4) years. There were 239, 189 and 201 patients in the low, moderate and high frequency groups, respectively. Significant differences were observed among the three groups in all timepoints of self-monitoring blood glucose except for the glucose before bedtime from 10 to 12 months after registration (all values<0.05), and the glucose level at each point in the high frequency group was lower than that in the other two groups. In the first three months after registration, there was no difference in the proportion of hypoglycemia among the three groups (>0.05). However, from 10 to 12 months after registration, the proportion [(, )] of hypoglycemia [3.34% (0.85%, 7.40%), 3.00% (0.78%, 6.17%), 1.81% (0.37%, 4.69%)] (=0.022) between groups (from low to high frequency groups) and hyperglycemia [4.04% (0, 12.16%), 1.88% (0, 7.80%), 0.81% (0, 3.87%)] (=0.001) were significantly different. The DSS function of mobile APP is helpful to the glucose management of adult patients with T1DM within 1 year after registration. The average blood glucose in adults with T1DM decreased, and the proportions of hyperglycemia and hypoglycemia were also reduced.

摘要

分析1型糖尿病(T1DM)成年患者使用智能手机移动应用程序(APP)的决策支持系统(DSS)后血糖的变化情况。在干预性研究中,收集了参加中国T1DM注册管理项目并使用糖糖圈®APP注册的成年T1DM患者的数据(包括注册时的一般信息)。注册后1年内,每3个月收集一次空腹血糖、三餐前及餐后血糖、睡前及夜间血糖。还收集并分析了总记录血糖值的频率以及不同血糖范围的比例,包括3.9 - 7.8 mmol/L(正常血糖)、低于3.9 mmol/L(低血糖)和高于13.9 mmol/L(高血糖)范围。根据DSS的每日使用频率将患者分为3组(低频/中频/高频组)。比较不同组间即时血糖、高血糖和低血糖比例随时间的变化情况,以及患者的基线特征和血糖特征。共纳入629例符合条件的T1DM患者,其中男性216例(34.3%),女性413例(65.7%),年龄(31.5±10.8)岁,病程[(,)]为1.2(0.1,7.4)年。低频组、中频组和高频组分别有239例、189例和201例患者。除注册后10至12个月的睡前血糖外,三组在自我监测血糖的所有时间点均观察到显著差异(所有P值<0.05),高频组各时间点的血糖水平均低于其他两组。注册后的前三个月,三组间低血糖比例无差异(P>0.05)。然而,注册后10至12个月,组间(从低频组到高频组)低血糖比例[3.34%(0.85%,7.40%),3.00%(0.78%,6.17%),1.81%(0.37%,4.69%)](P = 0.022)和高血糖比例[4.04%(0,12.16%),1.88%(0,7.80%),0.81%(0,3.87%)](P = 0.001)存在显著差异。移动APP的DSS功能有助于T1DM成年患者注册后1年内的血糖管理。T1DM成年患者的平均血糖下降,高血糖和低血糖比例也降低。

相似文献

1
[Analysis of glucose changes in adults with type 1 diabetes mellitus within 1 year after using mobile APP decision support system].[1型糖尿病成年患者使用移动应用决策支持系统后1年内血糖变化分析]
Zhonghua Yi Xue Za Zhi. 2022 Apr 26;102(16):1196-1201. doi: 10.3760/cma.j.cn112137-20211010-02240.
2
[The effect of mobile application based interactive peer support on glycemic control in patients with type 1 diabetes mellitus].[基于移动应用程序的交互式同伴支持对1型糖尿病患者血糖控制的影响]
Zhonghua Nei Ke Za Zhi. 2019 Dec 1;58(12):889-893. doi: 10.3760/cma.j.issn.0578-1426.2019.12.004.
3
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.在2型糖尿病患者中,使用基础胰岛素类似物的餐时50/50基础胰岛素与餐时胰岛素类似物混合制剂,并联合二甲双胍,以实现糖化血红蛋白(HbA1c)目标值以及餐前和餐后血糖水平:一项多国、24周、随机、开放标签、平行组对照研究。
Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016.
4
Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.青少年 1 型糖尿病患者行斋戒前血糖控制与斋戒期间血糖波动的相关性。
J Endocrinol Invest. 2017 Jul;40(7):741-744. doi: 10.1007/s40618-017-0633-y. Epub 2017 Feb 26.
5
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.吸入型 Technosphere 胰岛素对比门冬胰岛素治疗接受多次每日胰岛素注射的 1 型糖尿病患者的餐后血糖改善:STAT 研究。
Diabetes Technol Ther. 2018 Oct;20(10):639-647. doi: 10.1089/dia.2018.0200. Epub 2018 Sep 15.
6
Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study.移动糖尿病管理应用程序使用频率对血糖控制的影响:评估研究。
JMIR Mhealth Uhealth. 2019 Mar 7;7(3):e11933. doi: 10.2196/11933.
7
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.一项为期52周的多国、开放标签、平行组、非劣效性、达标治疗试验,在2型糖尿病患者中,比较德谷胰岛素与甘精胰岛素在基础-餐时胰岛素方案中联合门冬胰岛素的疗效。
Clin Ther. 2008 Nov;30(11):1976-87. doi: 10.1016/j.clinthera.2008.11.001.
8
Status and trends in the use of insulin analogs, insulin delivery systems and their association with glycemic control: comparison of the two consecutive recent cohorts of Japanese children and adolescents with type 1 diabetes mellitus.胰岛素类似物、胰岛素给药系统的使用现状及趋势及其与血糖控制的关联:对日本两连续队列1型糖尿病儿童及青少年的比较
J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):1-9. doi: 10.1515/jpem-2018-0329.
9
Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.斋月禁食期间1型糖尿病患者胰岛素泵治疗与多次皮下注射胰岛素方案的比较
Diabetes Technol Ther. 2017 Jun;19(6):349-354. doi: 10.1089/dia.2016.0418. Epub 2017 Mar 15.
10
An Intervention by a Patient-Designed Do-It-Yourself Mobile Device App Reduces HbA1c in Children and Adolescents with Type 1 Diabetes: A Randomized Double-Crossover Study.患儿自行设计的移动设备应用程序干预可降低 1 型糖尿病患儿和青少年的 HbA1c:一项随机双交叉研究。
Diabetes Technol Ther. 2018 Dec;20(12):797-805. doi: 10.1089/dia.2018.0255. Epub 2018 Nov 7.

引用本文的文献

1
Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review.临床决策支持系统在糖尿病护理中的应用:范围综述。
J Med Internet Res. 2023 Dec 8;25:e51024. doi: 10.2196/51024.